Surgery Partners (SGRY) Common Equity (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Common Equity data on file, last reported at $3.1 billion in Q1 2026.

• Quarterly Common Equity fell 1.84% year-over-year to $3.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 billion (down 1.84% YoY) and the FY2025 annual result came in at $3.1 billion, down 2.04% from the prior year.
• Common Equity retreated to $3.1 billion in Q1 2026 per SGRY's latest filing, from $3.1 billion in the prior quarter.
• The five-year high for Common Equity was $3.2 billion in Q4 2024, with the low at $1.7 billion in Q3 2025.
• Average Common Equity over 5 years is $2.8 billion, with a median of $3.0 billion recorded in 2023.
• Year-over-year, Common Equity jumped 82.09% in 2022 and slumped 44.42% in 2025.
• Surgery Partners' Common Equity stood at $2.9 billion in 2022, then increased by 3.18% to $3.0 billion in 2023, then increased by 5.34% to $3.2 billion in 2024, then declined by 2.04% to $3.1 billion in 2025, then decreased by 1.07% to $3.1 billion in 2026.
• Business Quant data shows SGRY's Common Equity at $3.1 billion in Q1 2026, $3.1 billion in Q4 2025, and $1.7 billion in Q3 2025.